candesartan | С09D А06
Tablets
Essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorthiazide is insufficient.
candesartan | С09D А06
Tablets
Essential hypertension, where monotherapy with candesartan cilexetil or hydrochlorthiazide is insufficient.
сastor oil | A06AB05
Solution for internal application
Oral use – for constipation; topical use - for the treatment of burns, wounds, ulcers, to soften the skin, remove dandruff, strengthen the hair.
cefazolin | J01DB04
Powder for injection
Infections caused by organisms susceptible to cefazolin: respiratory tract infections; infections of the genitourinary system; infections of skin and soft tissue; sepsis; endocarditis; biliary tract infections. Prevention of surgical infections.
cefazolin
Powder for injection
Treatment of dogs and cats suffering from peritonitis, also in diseases of the respiratory and urinary systems, infections of the skin, bones and joints, infected wounds, caused by microorganisms susceptible to cefazolin. Prevention of surgical infections in pre- and postoperative periods.
ceftiofur sodium
Powder for injection
Cattle: treatment of animals with respiratory diseases caused by Pasteurella (Mannheimia) haemolytica, Pasteurella multocida, Histophilus somni, and animals with acute interdigital necrobacillosis caused by Fusobacterium necrophorum, Bacteroides melaninogenicus, which are sensitive to ceftiofur.
Pigs: treatment of animals for diseases of the respiratory system caused by Actinobacillus (Haemophilus) pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis and Streptococcus suis sensitive to ceftiofur.
Horses: treatment of animals with respiratory diseases caused by Streptococcus zooepidemicus, which are sensitive to ceftiofur.
Dogs: treatment of animals suffering from arthritis, and in diseases of the respiratory system, urinary tract and skin caused by Escherichia coli and Proteus mirabilis, which are sensitive to ceftiofur.
Day-old chickens and turkeys: for the prevention of early mortality due to E. coli and Staphylococcus aureus, sensitive to ceftiofur.
cefotaxime | J01D D01
Powder for injection
Infections caused by sensitive microorganisms: infection of upper respiratory tract (tonsillitis, otitis); respiratory tract infections (bronchitis, pneumonia, pleurisy, abscesses); infections of the genitourinary system; septicemia, bacteremia; intra-abdominal infections (including peritonitis); infections of skin and soft tissues; bone and joint infections; meningitis (except listeriozny) and other infections of the central nervous system. Prevention of infection after surgery on the digestive tract, urological and obstetrical and gynecological operations.
ceftriaxone | J01D D04
Powder for injection
Treatment of infections due to drug-susceptible microorganisms, including: infections of ENT organs and respiratory tract (acute and chronic bronchitis, pneumonia, lung abscess, pleural empyema); skin and soft tissue infections (streptodermia); genitourinary infections (pyelitis, acute and chronic pyelonephritis, cystitis, prostatitis, epididymitis, gynecological infections, uncomplicated gonorrhea); intra-abdominal infections (biliary and gastrointestinal infections, peritonitis). For the treatment of sepsis and bacterial septicemia, infections of bones (osteomyelitis) and joints; bacterial meningitis and chancroid, syphilis, Lyme disease; typhoid fever, endocarditis; salmonellosis, infections in immunocompromised patients and for prophylaxis of postoperative purulent-septic complications.
сeftazidime | J01D D02
Powder for injection
Treatment of the mono- and mixed infections caused by susceptible microorganisms.
Severe infections: sepsis, bacteraemia, peritonitis, meningitis; infection in patients with reduced immunity; in patients in intensive care units, for example, with infected burns; respiratory tract infections, including infections of the lungs in patients with cystic fibrosis; infection of upper respiratory tract; urinary tract infections; infections of the skin and soft tissues; infections of the digestive tract, the biliary tract and the abdominal cavity; bone and joint infections; infections associated with hemodialysis and peritoneal dialysis. Prevention: surgery on the prostate (transurethral resection).
The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
If you have information about any adverse effects or other drug-related problems, please fill in the form